CalciMedica (CALC)
NASDAQ:CALC
Want to see CALC full AI Analyst Report?
Total Valuation
CalciMedica has a market cap or net worth of $10.19M. The enterprise value is $2.03M.
Market Cap$10.19M
Enterprise Value$2.03M
Share Statistics
CalciMedica has 15,798,031 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,798,031
Owned by Insiders31.85%
Owned by Institutions1.46%
Financial Efficiency
CalciMedica’s return on equity (ROE) is 4.45 and return on invested capital (ROIC) is -209.07%.
Return on Equity (ROE)4.45
Return on Assets (ROA)-2.18
Return on Invested Capital (ROIC)-209.07%
Return on Capital Employed (ROCE)-2.36
Revenue Per Employee0.00
Profits Per Employee-2.11M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CalciMedica is 0.4. CalciMedica’s PEG ratio is -54.43.
PE Ratio0.4
PS Ratio0.00
PB Ratio-14.90K
Price to Fair Value-14.90K
Price to FCF-4.66K
Price to Operating Cash Flow-0.46
PEG Ratio-54.43
Income Statement
In the last 12 months, CalciMedica had revenue of 0.00 and earned -29.56M in profits. Earnings per share was -1.97.
Revenue0.00
Gross Profit0.00
Operating Income-23.12M
Pretax Income-29.56M
Net Income-29.56M
EBITDA-28.09M
Earnings Per Share (EPS)-1.97
Cash Flow
In the last 12 months, operating cash flow was -21.16M and capital expenditures -19.00K, giving a free cash flow of -21.18M billion.
Operating Cash Flow-21.16M
Free Cash Flow-21.18M
Free Cash Flow per Share-1.34
Dividends & Yields
CalciMedica pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.14
52-Week Price Change-63.14%
50-Day Moving Average0.64
200-Day Moving Average2.58
Relative Strength Index (RSI)47.36
Average Volume (3m)71.94K
Important Dates
CalciMedica upcoming earnings date is Aug 18, 2026, After Close (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
CalciMedica as a current ratio of 3.58, with Debt / Equity ratio of 0.00%
Current Ratio3.58
Quick Ratio3.58
Debt to Market Cap<0.01
Net Debt to EBITDA0.06
Interest Coverage Ratio-16.26
Taxes
In the past 12 months, CalciMedica has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CalciMedica EV to EBITDA ratio is -3.52K, with an EV/FCF ratio of -4.66K.
EV to Sales0.00
EV to EBITDA-3.52K
EV to Free Cash Flow-4.66K
EV to Operating Cash Flow-4.67K
Balance Sheet
CalciMedica has $8.16M in cash and marketable securities with $0.00 in debt, giving a net cash position of $8.16M billion.
Cash & Marketable Securities$8.16M
Total Debt$0.00
Net Cash$8.16M
Net Cash Per Share$0.52
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for CalciMedica is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside1566.67% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast16.33%